Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MRE11 proximal polyadenylation site-mediated looping impacts transcription and genomic stability

ABSTRACT: Alternative polyadenylation (APA) generates transcript isoforms with variable 3' UTR lengths, but its regulatory role in DNA damage response (DDR) genes remains poorly understood. Here, we demonstrate that the proximal polyadenylation site (pPAS) of MRE11 engages in PAS-promoter looping to facilitate RNA polymerase recycling and maintain high promoter activity, a mechanism not well characterized in mammals. Deletion of the MRE11 pPAS disrupts this looping, reduces MRE11 transcription, impairs MRN complex levels, and phenocopies hypomorphic MRE11 mutations. MRE11pPAS-/- cells exhibit ectopic DNA replication and reduced viability under overgrowth conditions. EdU-seq revealed that aberrant DNA synthesis in MRE11pPAS-/- cells occurs primarily at intronic and intergenic regions. MRE11 ChIP-seq showed decreased binding at these regions, correlating with elevated DNA replication. Furthermore, several DDR genes with multiple PASs form PAS-promoter loops, suggesting a broader regulatory mechanism. Together, our findings establish the MRE11 pPAS as a critical noncoding element that maintains genome stability through transcriptional regulation via PAS-promoter looping.

ORGANISM(S): Homo sapiens

PROVIDER: GSE309806 | GEO | 2026/04/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

MRE11 proximal polyadenylation site-mediated looping impacts transcription and genomic stability [RNA-seq]

Project description:MRE11, a key regulator in maintaining genome integrity, has two main polyadenylation sites (PAS) in 3’UTR. There is a ~3 Kb difference between the proximal PAS (pPAS) and the distal PAS (dPAS). Therefore, using the pPAS can result in a ~3 Kb shorter MRE11 transcript which lacks a significant number of regulatory motifs in the 3’UTR. Analysis of the Cancer Genome Atlas revealed (10/160) mutations in MRE11 3’UTR, and intriguingly all these mutations are localized in pPAS. We observed that deletion of pPAS (~150 bp) using CRISPR caused ~50% reduction of MRE11 protein and mRNA. We hypothesize that pPAS regulates transcription of the MRE11 gene via ‘DNA looping’ where this cis element in the 3’UTR regulates the canonical MRE11 promoter. MRE11 hypomorphism in AT-like deficiency (ATLD) cells is well characterized, and MRE11pPAS-/- phenocopy these cells. Cell cycle analysis revealed that MRE11pPAS-/- cells grow slower with increased proportion of cells in the S/G2 phase with a concurrent decrease in the G0/G1 population. The most intriguing phenotype was in the context of G1/S checkpoint. Overgrown wild-type RPE1 cells when confluent exit the cell cycle and stop replicating. In contrast, MRE11pPAS-/- cells continued replicating leading to rapid cell death. Next, we systematically synchronized cells in G0/G1, and observed that EdU labeling in these G0/G1-paused cells shows increased BrdU+ population only in MRE11pPAS-/- cells. Induction of MRE11 in MRE11pPAS-/- cells can ‘rescue’ the ectopic replication of confluent cells, confirming that the phenotype is indeed due to reduced MRE11 expression. This suggests that optimal MRE11 is necessary for preventing unlicensed DNA replication in completely distinct scenarios. Our study highlights the importance of the 3’UTR in transcriptional regulation of MRE11 and its profound impact on genomic stability and cell growth.

2026-04-06 | GSE267579 | GEO

Mouse MRE11-RAD50-NBS1 is needed to start and extend meiotic DNA end resection [SSDS]

Project description:Nucleolytic resection of DNA ends is critical for homologous recombination, but its mechanism is not fully understood, particularly in mammalian meiosis. Here we examine roles of the conserved MRN complex (MRE11, RAD50, and NBS1) through genome-wide analysis of meiotic resection during spermatogenesis in mice with various MRN mutations, including several that cause chromosomal instability in humans. Meiotic DSBs form at elevated levels but remain unresected if Mre11 is conditionally deleted, thus MRN is required for both resection initiation and regulation of DSB numbers. Resection lengths are reduced to varying degrees in MRN hypomorphs or if MRE11 nuclease activity is attenuated in a conditional nuclease-dead Mre11 model. These findings unexpectedly establish that MRN is needed for longer-range extension of resection beyond that carried out by the orthologous proteins in budding yeast meiosis. Finally, resection defects are additively worsened by combining MRN and Exo1 mutations, and mice that are unable to initiate resection or have greatly curtailed resection lengths experience catastrophic spermatogenic failure. Our results elucidate MRN roles in meiotic DSB end processing and establish the importance of resection for mammalian meiosis.

2024-05-06 | GSE266271 | GEO

Mouse MRE11-RAD50-NBS1 is needed to start and extend meiotic DNA end resection [S1_Exo7T-seq]

2024-05-06 | GSE266258 | GEO

Mouse MRE11-RAD50-NBS1 is needed to start and extend meiotic DNA end resection [ChIP-seq]

2024-05-06 | GSE266151 | GEO

A truncated MRE11 form induced by SPRTN is deficient in DNA repair and radiosensitises cancer cells

Project description:he human MRE11/RAD50/NBS1 (MRN) complex plays a crucial role in sensing and repairing DNA DSB. MRE11 possesses 3’-5’ exonuclease and endonuclease activity and forms the core of the multifunctional MRN complex. We previously identified a C-terminally truncated form of MRE11 (TR-MRE11) associated with post-translational MRE11 degradation. Here we identified the approximate cleavage site of TR-MRE11 at 559-580 amino acids, its DNA damage repair function and the factors regulating TR-MRE11 accumulation. The nuclease enzymatic activity of TR-MRE11 was dramatically reduced, associated with a lack of DNA binding efficiency, whilst TR-MRE11 still interacted efficiently with RAD50 and NBS1. Lack of the MRE11 C-terminal resulted in deficient HR repair and increased cellular radiosensitivity. Knockdown of SprT-like N-terminal domain (SPRTN), an essential metalloprotease for DNA-protein crosslink repair, resulted in failure of MRE11 cleavage, with TR-MRE11 protein levels being positively correlated with SPRTN protein expression. The presence of this DNA repair-defective C-terminal truncation could explain the finding of high MRE11 expression, by immunohistochemistry using an antibody against MRE11 prior to the C-terminal, being associated with survival following radical radiotherapy in cancer patients. Ultimately, understanding the functional differences between intact and repair-defective MRE11 may lead to improvements in patient outcomes through a more informed choice of treatment.

2021-02-23 | PXD017964 | Pride

Mre11 suppresses replication stress and gene amplification proficiency

Project description:Gene amplification, copy-number increases of particular genes and surrounding genomic segments, promotes cancer progression and acquired therapy resistance. Thus, understanding genetic traits that confer gene amplification proficiency is important. The primary step for gene amplification is spontaneous DNA rearrangements initiated by DNA breaks. Here we show that mammalian cells became gene amplification-proficient when we knocked down Mre11/Rad50/Nbs1 (MRN) complex, a multifunctional complex that guards the genome from DNA breaks. Cells with reduced Mre11 experienced severe replication stress, with marked increases of single-stranded breaks followed by double-stranded breaks during DNA replication. Such breaks underlay for the increase in spontaneous gene amplification. Other traits associated with replication stress, such as impaired intra-S phase checkpoint and global transcriptional changes in DNA metabolism genes also contributed to gene amplification proficiency. Our results define Mre11 deficiency as a cause of replication stress and gene amplification proficiency and provide a candidate marker for aggressive cancer phenotypes. We sequenced four samples: 2 control, GFP-expressing samples and 2 Mre11 knockdown cells

2015-03-05 | E-GEOD-59487 | biostudies-arrayexpress

MRE11-RAD50-NBS1 activates Fanconi Anemia R-loop suppression at transcription-replication conflicts

Project description:Rad50 is a component of the conserved MRE11-RAD50-NBS1 (MRN) complex, which functions in genome stability and the cell’s ability to deal with stalled DNA replication forks. We identified Rad50 as a factor important for R-loop tolerance and thus mapped DNA:RNA hybrids in Rad50KO cells and compare them to previously reported wild-type and Sgs1KO profiles.

2019-10-31 | E-MTAB-7885 | biostudies-arrayexpress

Mre11 suppresses replication stress and gene amplification proficiency

2015-03-05 | GSE59487 | GEO

Targeting meiotic recombination 11 (MRE11) nuclease for personalization of epithelial ovarian cancer therapy

Project description:Platinum resistance is a clinical challenge in ovarian cancer. Platinating agents induce DNA damage which activate Mre11 nuclease directed DNA damage signalling and response (DDR). Upregulation of DDR may promote chemotherapy resistance. Here we have comprehensively evaluated Mre11 in epithelial ovarian cancers. In clinical cohort that received platinum- based chemotherapy (n=331), Mre11 protein overexpression was associated with aggressive phenotype and poor progression free survival (PFS) (p=0.002). In the ovarian cancer genome atlas (TCGA) cohort (n=498), Mre11 gene amplification was observed in a subset of serous tumours (5%) which correlated highly with Mre11 mRNA levels (p<0.0001). Altered Mre11 levels was linked with genome wide alterations that can influence platinum sensitivity. At the transcriptomic level (n=1259), Mre11 overexpression was associated with poor PFS (p=0.003). ROC analysis showed an area under the curve (AUC) of 0.642 for response to platinum-based chemotherapy. Pre-clinically, Mre11 depletion by gene knock down or blockade by small molecule inhibitor (Mirin) reversed platinum resistance in ovarian cancer cells and in 3D spheroid models. Importantly, Mre11 inhibition was synthetically lethal in platinum sensitive XRCC1 deficient ovarian cancer cells and 3D-spheroids. Selective cytotoxicity was associated with DNA double strand break (DSB) accumulation, S-phase cell cycle arrest and increased apoptosis. We conclude that pharmaceutical development of Mre11 inhibitors is a viable clinical strategy for platinum sensitization and synthetic lethality in ovarian cancer.

2022-07-04 | GSE160540 | GEO

Targeting meiotic recombination 11 (MRE11) nuclease for personalization of epithelial ovarian cancer therapy [2]

2022-07-04 | GSE198648 | GEO